Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

[ABO blood group expression in corneal allograft failures].

Ardjomand N, Komericki P, Klein A, Mattes D, El-Shabrawi Y, Radner H.

Ophthalmologe. 2005 Oct;102(10):981-6. German.

PMID:
15812644
2.

Expression of blood group antigens A and/or B in diseased corneas.

Ardjomand N, Reich ME, Radner H.

Curr Eye Res. 1998 Jun;17(6):650-5.

PMID:
9663855
3.
4.

ABO antigen blood-group compatibility in corneal transplantation.

Borderie VM, Lopez M, Vedie F, Laroche L.

Cornea. 1997 Jan;16(1):1-6.

PMID:
8985625
5.

[HLA antigenicity of normal and pathological corneas].

Delbosc B, Fellmann D, Piquot X, Montard M, Royer J.

J Fr Ophtalmol. 1990;13(11-12):535-41. French.

PMID:
2081843
6.

Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?

Hargrave SL, Mayhew E, Hegde S, Niederkorn J.

Transpl Immunol. 2003 Jan-Mar;11(1):79-89.

PMID:
12727479
7.
8.

Inappropriate expression of blood group antigens in hepatic allografts.

Bloom S, Fleming K, Chapman R, Neuberger J, Hubscher S.

Hepatology. 1994 Apr;19(4):876-81.

PMID:
8138260
9.

Cell subpopulations in failed human corneal grafts.

Kuffová L, Holán V, Lumsden L, Forrester JV, Filipec M.

Br J Ophthalmol. 1999 Dec;83(12):1364-9.

10.

ABO Blood groups and corneal transplantation.

Allansmith MR, Drell DW, Kajiyama G, Fine M.

Am J Ophthalmol. 1975 Mar;79(3):493-501.

PMID:
1092175
11.

Influence of donor storage time on corneal allograft survival.

Simon M, Fellner P, El-Shabrawi Y, Ardjomand N.

Ophthalmology. 2004 Aug;111(8):1534-8.

PMID:
15288984
12.

Expression of adhesion molecule CD44 on human corneas.

Zhu SN, Nölle B, Duncker G.

Br J Ophthalmol. 1997 Jan;81(1):80-4.

13.

Factors influencing the decline in endothelial cell density after corneal allograft rejection.

Claerhout I, Beele H, De Bacquer D, Kestelyn P.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4747-52.

PMID:
14578395
14.

Beneficial effects of histocompatibility in high-risk corneal transplantation.

Foulks GN, Sanfilippo F.

Am J Ophthalmol. 1982 Nov;94(5):622-9.

PMID:
6756156
15.

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.

Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, McClure MO, George AJ, Larkin DF.

Eur J Immunol. 2006 Mar;36(3):690-700.

16.

Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.

Ritter T, Yang J, Dannowski H, Vogt K, Volk HD, Pleyer U.

Transpl Immunol. 2007 Nov;18(2):101-7. Epub 2007 Jun 13.

PMID:
18005852
17.

[Immunohistochemical studies on wholemounts of the cornea and iris-ciliary body after corneal transplantation].

Yang P, Gong X, Zhou H, Zhao M, Huang X, Xie C, Cao X, Jin H.

Zhonghua Yan Ke Za Zhi. 1998 Jul;34(4):273-5, 19. Chinese.

PMID:
11877206
18.

Expression of HLA-G in human cornea, an immune-privileged tissue.

Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED.

Hum Immunol. 2003 Nov;64(11):1039-44.

PMID:
14602233
19.

B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.

Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T, Okumura K, Yagita H, Azuma M.

J Immunol. 2006 Nov 1;177(9):5928-35.

20.

ABO histo-blood group antigen expression on the graft endothelium long term after ABO-compatible, non-identical heart transplantation.

Koestner SC, Kappeler A, Schaffner T, Carrel TP, Mohacsi PJ.

Xenotransplantation. 2006 Mar;13(2):166-70.

PMID:
16623813

Supplemental Content

Support Center